JP2008515508A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515508A5 JP2008515508A5 JP2007535227A JP2007535227A JP2008515508A5 JP 2008515508 A5 JP2008515508 A5 JP 2008515508A5 JP 2007535227 A JP2007535227 A JP 2007535227A JP 2007535227 A JP2007535227 A JP 2007535227A JP 2008515508 A5 JP2008515508 A5 JP 2008515508A5
- Authority
- JP
- Japan
- Prior art keywords
- data
- kit
- drug
- pharmaceutical formulation
- nebulizer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 26
- 239000006199 nebulizer Substances 0.000 claims 21
- 238000002379 ultrasonic velocimetry Methods 0.000 claims 19
- 238000012377 drug delivery Methods 0.000 claims 16
- 238000000034 method Methods 0.000 claims 15
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims 12
- 239000003814 drug Substances 0.000 claims 12
- 229960002052 salbutamol Drugs 0.000 claims 12
- 229940079593 drug Drugs 0.000 claims 11
- 239000013583 drug formulation Substances 0.000 claims 11
- 238000009472 formulation Methods 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 9
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 6
- 229960004436 budesonide Drugs 0.000 claims 6
- 229960001361 ipratropium bromide Drugs 0.000 claims 6
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 5
- 238000012790 confirmation Methods 0.000 claims 4
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims 4
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 3
- 230000001088 anti-asthma Effects 0.000 claims 3
- 239000000924 antiasthmatic agent Substances 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- 239000007900 aqueous suspension Substances 0.000 claims 3
- 229940124748 beta 2 agonist Drugs 0.000 claims 3
- 150000003431 steroids Chemical class 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- 230000003044 adaptive effect Effects 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 239000003246 corticosteroid Substances 0.000 claims 2
- 229960000265 cromoglicic acid Drugs 0.000 claims 2
- 229940109248 cromoglycate Drugs 0.000 claims 2
- 229960002714 fluticasone Drugs 0.000 claims 2
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims 2
- 230000000977 initiatory effect Effects 0.000 claims 2
- 229910052708 sodium Inorganic materials 0.000 claims 2
- 239000011734 sodium Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0422413.5 | 2004-10-08 | ||
| GBGB0422413.5A GB0422413D0 (en) | 2004-10-08 | 2004-10-08 | High efficiency nebulisation |
| GB0501573.0 | 2005-01-25 | ||
| GBGB0501573.0A GB0501573D0 (en) | 2004-10-08 | 2005-01-25 | Methods and kits for delivering drugs by nebulisation |
| PCT/GB2005/003645 WO2006037948A2 (en) | 2004-10-08 | 2005-09-22 | Methods and kits for delivering drugs by nebulisation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008515508A JP2008515508A (ja) | 2008-05-15 |
| JP2008515508A5 true JP2008515508A5 (https=) | 2008-08-28 |
| JP5072596B2 JP5072596B2 (ja) | 2012-11-14 |
Family
ID=35667805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007535227A Expired - Fee Related JP5072596B2 (ja) | 2004-10-08 | 2005-09-22 | 噴霧による薬剤送達のための方法およびキット |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20060078505A1 (https=) |
| EP (2) | EP2258343A1 (https=) |
| JP (1) | JP5072596B2 (https=) |
| KR (1) | KR20070109974A (https=) |
| CN (1) | CN101035510A (https=) |
| AU (1) | AU2005291120B2 (https=) |
| BR (1) | BRPI0516262A (https=) |
| CA (1) | CA2582420A1 (https=) |
| CZ (1) | CZ2007327A3 (https=) |
| GB (2) | GB0422413D0 (https=) |
| HU (1) | HUP0700335A3 (https=) |
| IL (1) | IL181531A0 (https=) |
| IS (1) | IS8642A (https=) |
| NO (1) | NO20071751L (https=) |
| NZ (1) | NZ553359A (https=) |
| WO (1) | WO2006037948A2 (https=) |
| ZA (1) | ZA200702371B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| ATE446581T1 (de) * | 2004-03-12 | 2009-11-15 | Trinity College Dublin | Magnetoresistives medium |
| GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
| US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| US20070178050A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an increased lung depositon |
| US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
| US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| JP2009526858A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | コルチコステロイド溶液を製造する方法 |
| US20100056559A1 (en) | 2006-05-19 | 2010-03-04 | Boehringer Ingelheim International Gmbh | Propellant-free aerosol formulation for inhalation |
| AU2007267523B2 (en) * | 2006-05-26 | 2012-02-09 | Dey, L.P. | Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists |
| US20080035141A1 (en) * | 2006-06-16 | 2008-02-14 | Warner W R | Aerosolized therapy kit |
| GB0700380D0 (en) | 2007-01-09 | 2007-02-14 | Breath Ltd | Storage Of Ampoules |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US10011906B2 (en) | 2009-03-31 | 2018-07-03 | Beohringer Ingelheim International Gmbh | Method for coating a surface of a component |
| WO2010133294A2 (de) | 2009-05-18 | 2010-11-25 | Boehringer Ingelheim International Gmbh | Adapter, inhalationseinrichtung und zerstäuber |
| US20130255678A1 (en) * | 2009-07-01 | 2013-10-03 | Microdose Therapeutx, Inc. | Nebulizer for infants and respiratory compromised patients |
| EA026241B1 (ru) | 2009-11-25 | 2017-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Распылитель |
| JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| PL2835146T3 (pl) | 2013-08-09 | 2021-04-06 | Boehringer Ingelheim International Gmbh | Nebulizator |
| EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
| EA035261B1 (ru) | 2014-05-07 | 2020-05-21 | Бёрингер Ингельхайм Интернациональ Гмбх | Небулайзер и контейнер |
| AU2015257878B2 (en) | 2014-05-07 | 2019-08-08 | Boehringer Ingelheim International Gmbh | Container, nebulizer and use |
| HUE055604T2 (hu) | 2014-05-07 | 2021-12-28 | Boehringer Ingelheim Int | Porlasztó |
| WO2018071435A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
| CN119028506B (zh) * | 2024-10-31 | 2025-01-24 | 柯诺物联网技术(山东)有限公司 | 一种医药数据追溯方法及系统 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5404871A (en) * | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
| US5363842A (en) * | 1991-12-20 | 1994-11-15 | Circadian, Inc. | Intelligent inhaler providing feedback to both patient and medical professional |
| US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| US5906202A (en) * | 1996-11-21 | 1999-05-25 | Aradigm Corporation | Device and method for directing aerosolized mist to a specific area of the respiratory tract |
| US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
| WO2001026020A1 (en) * | 1999-10-01 | 2001-04-12 | Glaxo Group Limited | Patient data monitoring system |
| PE20010720A1 (es) * | 1999-12-11 | 2001-07-26 | Glaxo Group Ltd | Distribuidor de medicamento |
| US20020183292A1 (en) * | 2000-10-31 | 2002-12-05 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| JP2005508220A (ja) * | 2001-10-24 | 2005-03-31 | パーリ・ゲーエムベーハー | 薬用組成物調製用具 |
| JP2003221335A (ja) * | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
| US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| JP2003159332A (ja) * | 2001-11-27 | 2003-06-03 | Omron Corp | ネブライザ、サーバ、ネブライザシステム、ネブライザにおける薬剤判別方法、ネブライザにおける薬量検出方法、ネブライザシステムにおける情報管理方法、ネブライザ情報管理プログラム、および該プログラムを記録する記録媒体 |
| JP2005527260A (ja) * | 2002-01-25 | 2005-09-15 | グラクソ グループ リミテッド | 薬剤ディスペンサ |
| GB2396825B (en) | 2002-11-20 | 2004-12-08 | Profile Respiratory Systems Lt | Improved inhalation method and apparatus |
| GB2395437C (en) | 2002-11-20 | 2010-10-20 | Profile Respiratory Systems Ltd | Improved inhalation method and apparatus |
-
2004
- 2004-10-08 GB GBGB0422413.5A patent/GB0422413D0/en not_active Ceased
-
2005
- 2005-01-25 GB GBGB0501573.0A patent/GB0501573D0/en not_active Ceased
- 2005-05-02 US US11/119,352 patent/US20060078505A1/en not_active Abandoned
- 2005-09-22 HU HU0700335A patent/HUP0700335A3/hu unknown
- 2005-09-22 KR KR1020077007825A patent/KR20070109974A/ko not_active Ceased
- 2005-09-22 CN CNA2005800339912A patent/CN101035510A/zh active Pending
- 2005-09-22 NZ NZ553359A patent/NZ553359A/en not_active IP Right Cessation
- 2005-09-22 JP JP2007535227A patent/JP5072596B2/ja not_active Expired - Fee Related
- 2005-09-22 CZ CZ20070327A patent/CZ2007327A3/cs unknown
- 2005-09-22 EP EP10174847A patent/EP2258343A1/en not_active Ceased
- 2005-09-22 CA CA002582420A patent/CA2582420A1/en not_active Abandoned
- 2005-09-22 AU AU2005291120A patent/AU2005291120B2/en not_active Ceased
- 2005-09-22 BR BRPI0516262-9A patent/BRPI0516262A/pt not_active IP Right Cessation
- 2005-09-22 WO PCT/GB2005/003645 patent/WO2006037948A2/en not_active Ceased
- 2005-09-22 ZA ZA200702371A patent/ZA200702371B/xx unknown
- 2005-09-22 EP EP05784738A patent/EP1796638A2/en not_active Withdrawn
-
2007
- 2007-02-25 IL IL181531A patent/IL181531A0/en unknown
- 2007-04-02 NO NO20071751A patent/NO20071751L/no not_active Application Discontinuation
- 2007-05-08 IS IS8642A patent/IS8642A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008515508A5 (https=) | ||
| WO2006037948B1 (en) | Methods and kits for delivering drugs by nebulisation | |
| Chan et al. | Advances in device and formulation technologies for pulmonary drug delivery | |
| JP7730443B2 (ja) | オピオイド過剰摂取を処置するための組成物および方法 | |
| CN101553210A (zh) | 经吸入输送药物的方法和系统 | |
| HU229552B1 (en) | Pharmaceutical composition containing mixture of organic compounds for the treatment of air way diseases | |
| CN101801378A (zh) | 治疗药物的新型组合 | |
| TW200938232A (en) | Novel dosage and formulation | |
| US20220047627A1 (en) | Non-infective nasal symptom management compositions and methods | |
| EP2934479B1 (en) | Ciclesonide for the treatment of airway disease in horses | |
| CN106470700A (zh) | 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合 | |
| Adi et al. | Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers | |
| WO2015027848A1 (zh) | 含有帕拉米韦和/或其衍生物制剂的给药方法 | |
| EP4255391A1 (en) | Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infection | |
| EP1599209B1 (en) | Inhalation composition | |
| JP2025540138A (ja) | 吸入可能なホルモン受容体アゴニスト製剤 | |
| Singh et al. | Novel aerosol delivery devices | |
| EP2563364A1 (en) | Combination of carmoterol and fluticasone for use in the treatment respiratory diseases | |
| WO2004017914A2 (en) | Inhalation composition | |
| AU2016208131A1 (en) | Pharmaceutical combination | |
| WO2013026269A1 (zh) | 制备用于治疗呼吸道疾病的定量喷雾吸入剂的工艺方法 | |
| JP2011500731A5 (https=) | ||
| MXPA05001901A (es) | Composiciones para inhalacion con altas proporciones de medicamento. | |
| More et al. | Formulation and Development of a" Pressurised Metered Dose Inhalation" beclomethasone 250 mcg | |
| JP2011509936A5 (https=) |